Literature DB >> 21123971

Immunoglobulin G4 (IgG4)-positive or -negative ocular adnexal benign lymphoid lesions in relation to systemic involvement.

Toshihiko Matsuo1, Kouichi Ichimura, Yasuharu Sato, Yasushi Tanimoto, Katsuyuki Kiura, Sou Kanazawa, Toshiaki Okada, Tadashi Yoshino.   

Abstract

The purpose of this study is to determine the relationship of ocular adnexal benign or reactive lymphoid hyperplasia, including orbital pseudotumor, with immunoglobulin G4 (IgG4)-related diseases. Medical charts of 9 consecutive patients with ocular adnexal benign lymphoid lesions, seen in the Department of Ophthalmology, Okayama University Hospital, were reviewed, and pathological sections were restained immunohistochemically for IgG4-, IgG-, and CD138-positive plasma cells. The diagnosis of IgG4-positive lesions was based on 10 or more IgG4-positive plasma cells in a high-power field and greater than 40% ratios of IgG4-positive plasma cells/CD138-positive plasma cells and IgG4-positive plasma cells/IgG-positive plasma cells. IgG4-positive lesions were determined as absent in 5 patients (4 with bilateral lacrimal/orbital lesions and one with a unilateral conjunctival lesion), none of whom showed systemic manifestations. In contrast, IgG4-positive lesions were present in 4 patients (3 with bilateral lacrimal/orbital lesions and one with a unilateral lacrimal/orbital lesion), who showed systemic manifestations : one with Hashimoto thyroiditis, one with IgG4-positive bilateral interstitial lung disease and hepatic inflammatory pseudotumor, one with bilateral interstitial lung disease, and one with systemic lymphadenopathy and antiphospholipid syndrome. In conclusion, IgG4-positive ocular adnexal benign lymphoid lesions might be used as a benchmark for the probable presence of other systemic lymphoid lesions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21123971     DOI: 10.3960/jslrt.50.129

Source DB:  PubMed          Journal:  J Clin Exp Hematop        ISSN: 1346-4280


  14 in total

Review 1.  Systemic immunoglobulin G4 (IgG4) disease and idiopathic orbital inflammation; removing 'idiopathic' from the nomenclature?

Authors:  D Lindfield; K Attfield; A McElvanney
Journal:  Eye (Lond)       Date:  2012-02-03       Impact factor: 3.775

Review 2.  Nephrotic syndrome during the tapering of oral steroids after pathological diagnosis of Kimura disease from a lacrimal gland mass: case report and review of 10 Japanese patients.

Authors:  Toshihiko Matsuo; Takehiro Tanaka; Masaru Kinomura
Journal:  J Clin Exp Hematop       Date:  2017

3.  Isolated Conjunctival Inflammation Suggestive of IgG4-Related Disease.

Authors:  Hassan A Aziz; Alexandra Villa-Forte; Thomas P Plesec; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2015-08-26

4.  Rituximab for the treatment of IgG4-related orbital disease: experience from five cases.

Authors:  A Wu; N H Andrew; A Tsirbas; P Tan; A Gajdatsy; D Selva
Journal:  Eye (Lond)       Date:  2014-10-24       Impact factor: 3.775

5.  Immunoglobulin G4-positive Sclerosing Idiopathic Orbital Inflammation: New Neuro-ophthalmological Presentations.

Authors:  Nagham Al-Zubidi; Hidehiro Oku; Elizabeth Verner-Cole; Patricia Chévez-Barrios; Masahiro Tonari; Takuji Kurimoto; Motomu Tsuji; Tsunehiko Ikeda; Andrew G Lee
Journal:  Neuroophthalmology       Date:  2013-01-29

Review 6.  Immunoglobulin G4-related diseases in the head and neck: a systematic review.

Authors:  Graeme B Mulholland; Caroline C Jeffery; Paras Satija; David W J Côté
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-06-20

7.  Immunoglobulin G4-related disease (IgG4-RD) in the orbit: mucosa-associated lymphoid tissue (MALT)-type lymphomas.

Authors:  Krzysztof Oleś; Jacek Składzień; Wojciech Szczepański; Krzysztof Okoń; Joanna Leszczyńska; Emilia Bojanowska; Krzysztof Bartuś; Joanna Mika
Journal:  Med Sci Monit       Date:  2015-04-10

8.  IgG4 immunostaining and its implications in orbital inflammatory disease.

Authors:  Amanda J Wong; Stephen R Planck; Dongseok Choi; Christina A Harrington; Megan L Troxell; Donald C Houghton; Patrick Stauffer; David J Wilson; Hans E Grossniklaus; Roger A Dailey; John D Ng; Eric A Steele; Gerald J Harris; Craig Czyz; Jill A Foster; Valerie A White; Peter J Dolman; Michael Kazim; Payal J Patel; Deepak P Edward; Hind al Katan; Hailah al Hussain; Dinesh Selva; R Patrick Yeatts; Bobby S Korn; Don O Kikkawa; James T Rosenbaum
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

9.  Clinical and pathological characteristics of IgG4-related interstitial lung disease.

Authors:  Xiaoting Lv; Feng Gao; Qicai Liu; Sheng Zhang; Zhihua Huang; Yongping Zhu; Haiyang Zong; Quwen Li; Sanyan Li
Journal:  Exp Ther Med       Date:  2017-11-23       Impact factor: 2.447

Review 10.  Therapeutic approach to IgG4-related disease: A systematic review.

Authors:  Pilar Brito-Zerón; Belchin Kostov; Xavier Bosch; Nihan Acar-Denizli; Manuel Ramos-Casals; John H Stone
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.